PAR Pharmaceutical  
ProfilePrioritiesParFactsGenericsAlliancesAwardsHistory

About ParProductsInvestorsMediaCustomersCareers
Home / About Par / ParFacts

Introduction
1987 Listed on New York Stock Exchange
775 Employees
$206 million Market cap at December 31, 2000
$1.1 billion Market cap at December 31, 2005
7 Consecutive years of record sales (from 1998 to 2004)
$433.2 million 2005 revenue
$12.6 million 2005 net income*
110+ Currently marketed products
16 New product launches in 2005
22 ANDAs filed in 2005
59 ANDAs pending approval
$28+ billion US sales of the 59 branded equivalents
20 Strategic partners

* Excludes certain infrequent items in 2005.
† Including partner companies.